Literature DB >> 23670085

Peritoneal changes in patients on long-term peritoneal dialysis.

Raymond T Krediet1, Dirk G Struijk.   

Abstract

Long-term peritoneal dialysis can lead to morphological and functional changes in the peritoneum. Although the range of morphological alterations is known for the peritoneal dialysis population as a whole, these changes will not occur in every patient in the same sequence and to the same extent. Longitudinal studies are therefore required to help identify which patients might develop the changes. Although longitudinal studies using peritoneal biopsies are not possible, analyses of peritoneal effluent biomarkers that represent morphological alterations could provide insight. Longitudinal studies on peritoneal transport have been performed, but follow-up has often been too short and an insufficient number of parameters have been investigated. This Review will firstly describe peritoneal morphology and structure and will then focus on peritoneal effluent biomarkers and their changes over time. Net ultrafiltration will also be discussed together with the transport of small solutes. Data on the peritoneal transport of serum proteins show that serum protein levels do not increase to the same extent as levels of small solutes with long-term peritoneal dialysis. Early alterations in peritoneal transport must be distinguished from alterations that only develop with long-term peritoneal dialysis. Early alterations are related to vasoactive mediators, whereas later alterations are related to neoangiogenesis and fibrosis. Modern peritoneal dialysis should focus on the early detection of long-term membrane alterations by biomarkers--such as cancer antigen 125, interleukin-6 and plasminogen activator inhibitor 1--and the improved assessment of peritoneal transport.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23670085     DOI: 10.1038/nrneph.2013.99

Source DB:  PubMed          Journal:  Nat Rev Nephrol        ISSN: 1759-5061            Impact factor:   28.314


  157 in total

Review 1.  Clinical advantages of new peritoneal dialysis solutions.

Authors:  Raymond T Krediet; Roos van Westrhenen; Machteld M Zweers; Dirk G Struijk
Journal:  Nephrol Dial Transplant       Date:  2002       Impact factor: 5.992

2.  Peritoneal thickening is not inevitable in long-term peritoneal dialysis and is associated with peritoneal transport characteristics: a two-centre sonographic study.

Authors:  Tsung-Chun Lee; Ju-Yeh Yang; Hsiu-Po Wang; Tun-Jun Tsai; Yu Yang
Journal:  Nephrol Dial Transplant       Date:  2007-11-27       Impact factor: 5.992

3.  A method to test blood flow limitation of peritoneal-blood solute transport.

Authors:  M Kim; J Lofthouse; M F Flessner
Journal:  J Am Soc Nephrol       Date:  1997-03       Impact factor: 10.121

4.  A case of encapsulating peritoneal sclerosis at the clinical early stage with high concentration of matrix metalloproteinase-2 in peritoneal effluent.

Authors:  Yoshinori Masunaga; Ichiro Hirahara; Yasumasa Shimano; Megumi Kurosu; Osamu Iimura; Yukio Miyata; Morimasa Amemiya; Sumiko Homma; Eiji Kusano; Yasushi Asano
Journal:  Clin Exp Nephrol       Date:  2005-03       Impact factor: 2.801

5.  Growth factors VEGF and TGF-beta1 in peritoneal dialysis.

Authors:  M M Zweers; D R de Waart; W Smit; D G Struijk; R T Krediet
Journal:  J Lab Clin Med       Date:  1999-08

Review 6.  Advanced glycation end products: a Nephrologist's perspective.

Authors:  D S Raj; D Choudhury; T C Welbourne; M Levi
Journal:  Am J Kidney Dis       Date:  2000-03       Impact factor: 8.860

7.  Early diagnostic markers for encapsulating peritoneal sclerosis: a case-control study.

Authors:  Denise E Sampimon; Mario R Korte; Deirisa Lopes Barreto; Anniek Vlijm; Rudy de Waart; Dirk G Struijk; Raymond T Krediet
Journal:  Perit Dial Int       Date:  2010-02-01       Impact factor: 1.756

8.  Free water transport, small pore transport and the osmotic pressure gradient.

Authors:  Alena Parikova; Watske Smit; Machteld M Zweers; Dirk G Struijk; Raymond T Krediet
Journal:  Nephrol Dial Transplant       Date:  2007-11-05       Impact factor: 5.992

9.  Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders.

Authors:  L P Aiello; R L Avery; P G Arrigg; B A Keyt; H D Jampel; S T Shah; L R Pasquale; H Thieme; M A Iwamoto; J E Park
Journal:  N Engl J Med       Date:  1994-12-01       Impact factor: 91.245

10.  Predictors of baseline peritoneal transport status in Australian and New Zealand peritoneal dialysis patients.

Authors:  Markus Rumpsfeld; Stephen P McDonald; David M Purdie; John Collins; David W Johnson
Journal:  Am J Kidney Dis       Date:  2004-03       Impact factor: 8.860

View more
  45 in total

1.  The Mutual Relationship Between Peritonitis and Peritoneal Transport.

Authors:  Sadie van Esch; Anouk T N van Diepen; Dirk G Struijk; Raymond T Krediet
Journal:  Perit Dial Int       Date:  2014-11-13       Impact factor: 1.756

Review 2.  Should peritoneal resting be advised in ultrafiltration failure associated with a fast peritoneal solute transport status?

Authors:  Raymond T Krediet
Journal:  Perit Dial Int       Date:  2014 Nov-Dec       Impact factor: 1.756

3.  Sensitive and non-invasive method for the in vivo analysis of membrane permeability in small animals.

Authors:  Andrea Fernandez-Carrera; Eva Vigo; Carla Regueiro-Rodríguez; África González-Fernández; David Olivieri; Luiz S Aroeira
Journal:  Lab Invest       Date:  2017-07-24       Impact factor: 5.662

4.  Role of miRNA-21/PTEN on the high glucose-induced EMT in human mesothelial peritoneal cells.

Authors:  Lina Yang; Yi Fan; Xiuli Zhang; Lili Gao; Jianfei Ma
Journal:  Am J Transl Res       Date:  2018-08-15       Impact factor: 4.060

5.  The MicroRNA-199a/214 Cluster Targets E-Cadherin and Claudin-2 and Promotes High Glucose-Induced Peritoneal Fibrosis.

Authors:  Mingwen Che; Tiantian Shi; Shidong Feng; Huan Li; Xiaomin Zhang; Ning Feng; Weijuan Lou; Jianhua Dou; Guangbo Tang; Chen Huang; Guoshuang Xu; Qi Qian; Shiren Sun; Lijie He; Hanmin Wang
Journal:  J Am Soc Nephrol       Date:  2017-04-20       Impact factor: 10.121

6.  KIM-1: friend or foe?

Authors:  Olivier Devuyst
Journal:  Perit Dial Int       Date:  2014 Jan-Feb       Impact factor: 1.756

7.  The PPARβ/δ agonist GW501516 attenuates peritonitis in peritoneal fibrosis via inhibition of TAK1-NFκB pathway in rats.

Authors:  Xuesong Su; Guangyu Zhou; Yanqiu Wang; Xu Yang; Li Li; Rui Yu; Detian Li
Journal:  Inflammation       Date:  2014-06       Impact factor: 4.092

8.  Dimethylaminomicheliolide ameliorates peritoneal fibrosis through the activation of autophagy.

Authors:  Shuting Li; Fenfen Peng; Wangqiu Gong; Jiayu Wu; Yuxian Wang; Zhaozhong Xu; Wenting Liu; Hongyu Li; Bohui Yin; Ying Zhang; Sijia Chen; Congwei Luo; Peilin Li; Yihua Chen; Qianyin Huang; Weidong Zhou; Haibo Long
Journal:  J Mol Med (Berl)       Date:  2019-03-11       Impact factor: 4.599

9.  Glucose Exposure in Peritoneal Dialysis Is a Significant Factor Predicting Peritonitis.

Authors:  Herma Uiterwijk; Casper F M Franssen; Johanna Kuipers; Ralf Westerhuis; Ferdau L Nauta
Journal:  Am J Nephrol       Date:  2020-02-18       Impact factor: 3.754

10.  Peritoneal Dialysis Fluid and Some of Its Components Potentiate Fibrocyte Differentiation.

Authors:  Sarah E Herlihy; Hannah E Starke; Melisa Lopez-Anton; Nehemiah Cox; Katayoon Keyhanian; Donald J Fraser; Richard H Gomer
Journal:  Perit Dial Int       Date:  2015-10-22       Impact factor: 1.756

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.